Baculovirus capsid display in vaccination schemes: effect of a previous immunity against the vector on the cytotoxic response to delivered antigens

2018 ◽  
Vol 102 (23) ◽  
pp. 10139-10146
Author(s):  
Paula Molinari ◽  
Guido N. Molina ◽  
Eugenia Tavarone ◽  
María Paula Del Médico Zajac ◽  
Gabriel Morón ◽  
...  
2015 ◽  
Vol 6 ◽  
Author(s):  
TABORDA NATALIA ◽  
GONZALEZ SANDRA ◽  
ALVAREZ CRISTIAM ◽  
CORREA LUIS ◽  
MONTOYA CARLOS ◽  
...  

Immunology ◽  
2017 ◽  
Vol 152 (4) ◽  
pp. 660-676 ◽  
Author(s):  
Maria T. Cencioni ◽  
Roberta Magliozzi ◽  
Richard Nicholas ◽  
Rehiana Ali ◽  
Omar Malik ◽  
...  

Biomedicines ◽  
2018 ◽  
Vol 6 (3) ◽  
pp. 81 ◽  
Author(s):  
Marija Vujadinovic ◽  
Jort Vellinga

Adenoviral vectored vaccines against infectious diseases are currently in clinical trials due to their capacity to induce potent antigen-specific B- and T-cell immune responses. Heterologous prime-boost vaccination with adenoviral vector and, for example, adjuvanted protein-based vaccines can further enhance antigen-specific immune responses. Although leading to potent immune responses, these heterologous prime-boost regimens may be complex and impact manufacturing costs limiting efficient implementation. Typically, adenoviral vectors are engineered to genetically encode a transgene in the E1 region and utilize the host cell machinery to express the encoded antigen and thereby induce immune responses. Similarly, adenoviral vectors can be engineered to display foreign immunogenic peptides on the capsid-surface by insertion of antigens in capsid proteins hexon, fiber and protein IX. The ability to use adenoviral vectors as antigen-display particles, with or without using the genetic vaccine function, greatly increases the versatility of the adenoviral vector for vaccine development. This review describes the application of adenoviral capsid antigen-display vaccine vectors by focusing on their distinct advantages and possible limitations in vaccine development.


Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Alain J Poncelet ◽  
Johnatan Vercruysse ◽  
Alain Saliez ◽  
Pierre Gianello

Purpose Several reports have highlighted the low immunogenic profile of MSCs. Therefore, we decided to test in vivo the humoral response to allogeneic MSCs transplantation and the effect of transient immunosuppression in a porcine model. Methods/Material MHC-controlled mini-swine SLA cd and SLA dd were used as donor and recipients, respectively. Two sites of transplantation were selected: subcutaneous and intracardiac. In our control group (n = 5), animals received no immunosuppression. In the study group (n = 11), nearly 1 x 10 6 allogeneic MSC/kg were injected. FK-506 was given from day 0 –12 and adjusted to therapeutic blood levels. Sera were serially collected up to one year after transplantation. The presence of specific anti-donor IgM and IgG was tested by flow cytometry and by a complement-mediated cytotoxicity assay. Results In the control group, all animals developed humoral responses in both IgM/G classes that persisted up to ten weeks. When transplanted subcutaneously, a single injection failed to elicit a complement-mediated cytotoxic response but subsequent re-challenge did. In the study group, only 2/11 FK-treated animals developed a transient humoral response, both in IgM and IgG, whereas all others failed to develop donor-specific antibodies. However, none of the sera tested from those 11 animals could elicit a complement-mediated cytotoxic response. Conclusion Allogeneic MSCs injected subcutaneously or intra-cardially can elicit prolonged humoral responses despite their putative low immunogenic profile. As already shown for experimental allogeneic organ transplantation, a transient immunosuppressive regimen can overcome the initial B cell response. Our result suggests that in vitro and in vivo characteristics of MSCs might differ and emphasizes the importance of pursuing research on allogeneic stem cell transplantation.


2020 ◽  
Vol 9 (6) ◽  
pp. 14754-14770
Author(s):  
Leandro Antonio de Oliveira ◽  
Rejane Maria Pereira da Silva ◽  
Andrea Cecilia Dorion Rodas ◽  
Ricardo M. Souto ◽  
Renato Altobelli Antunes

Sign in / Sign up

Export Citation Format

Share Document